Home/ Stocks/ GUTS

Fractyl Health, Inc. Common Stock

GUTS XNAS

$0.43 +0.07 (+16.69%) ▲ 15-min delayed

Open

$0.45

High

$0.45

Low

$0.42

Volume

8.40M

Market Cap

$68.39M

About Fractyl Health, Inc. Common Stock

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 109 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-45,603,000	$-0.71
Q2 2025	$0	$-27,889,000	$-0.57
Q1 2025	$0	$-23,735,000	$-0.49
Q3 2024	$14.0K	$-23,173,000	$-0.48

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for GUTS yet. Check out our latest market news or earnings calendar.

Get GUTS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Fractyl Health, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.